| abstract |
The use of amoxycillin trihydrate and potassium clavulanate in combination, in a weight ratio of 7:1, the weights being expressed as the free parent acids amoxycillin and clavulanic acid, for the manufacture of a pediatric medicament substantially as described in the specification for treating bacterial infections in pediatric patients which medicament is administered twice daily (bid), at a dosage of between 20 and 70 mg/kg/day of amoxycillin and pro rata amounts of clavulanic acid. |